赛托生物
(300583)
| 流通市值：28.69亿 | | | 总市值：29.35亿 |
| 流通股本：1.85亿 | | | 总股本：1.90亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 244,395,524.04 | 1,279,783,092.49 | 923,225,289.28 | 663,655,673.27 |
| 营业收入 | 244,395,524.04 | 1,279,783,092.49 | 923,225,289.28 | 663,655,673.27 |
| 二、营业总成本 | 238,473,780.69 | 1,244,249,092.87 | 877,557,142.67 | 612,618,989.7 |
| 营业成本 | 174,821,291.66 | 994,242,629.97 | 684,779,546 | 483,644,813.41 |
| 税金及附加 | 3,061,577.19 | 13,767,928.33 | 9,682,676.11 | 6,655,960.36 |
| 销售费用 | 4,162,068.72 | 15,666,356.24 | 11,715,316.93 | 8,197,419.78 |
| 管理费用 | 31,757,483.5 | 128,235,023.09 | 104,486,456.13 | 69,397,336.54 |
| 研发费用 | 14,321,901.84 | 55,076,380.87 | 41,727,262.07 | 27,913,511.71 |
| 财务费用 | 10,349,457.78 | 37,260,774.37 | 25,165,885.43 | 16,809,947.9 |
| 其中:利息费用 | 10,368,492.38 | 37,658,706.07 | 26,654,991.16 | 17,639,329.53 |
| 其中:利息收入 | 1,159,909.07 | 4,736,527.78 | 3,818,006.02 | 2,511,430.61 |
| 加:投资收益 | 1,787,943.81 | 3,611,814.66 | 3,448,768.16 | 1,845,404.08 |
| 资产处置收益 | - | 138,867.19 | 165,229.15 | 165,229.15 |
| 资产减值损失(新) | -2,244,799.22 | -13,167,357.38 | -1,752,604.51 | -6,536,339.92 |
| 信用减值损失(新) | -581,690.84 | -5,352,684.74 | -3,225,910.96 | -2,861,064.98 |
| 其他收益 | 3,198,873.33 | 11,974,160.07 | 3,207,567.35 | 2,181,061.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 8,082,070.43 | 32,738,799.42 | 47,511,195.8 | 45,830,973.15 |
| 加:营业外收入 | 100.09 | 25,031,289.2 | 24,907,127.99 | 24,724,652.33 |
| 减:营业外支出 | 1,394.66 | 4,290,505.01 | 707,904.87 | 223,394.54 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 8,080,775.86 | 53,479,583.61 | 71,710,418.92 | 70,332,230.94 |
| 减:所得税费用 | 4,369,303.15 | 4,932,433.43 | 3,900,391.76 | 3,552,464.26 |
| 六、净利润 | 3,711,472.71 | 48,547,150.18 | 67,810,027.16 | 66,779,766.68 |
| 持续经营净利润 | 3,711,472.71 | 48,547,150.18 | 67,810,027.16 | 66,779,766.68 |
| 归属于母公司股东的净利润 | 3,070,728.65 | 45,603,990.98 | 61,157,474.42 | 59,967,581.48 |
| 少数股东损益 | 640,744.06 | 2,943,159.2 | 6,652,552.74 | 6,812,185.2 |
| (一)基本每股收益 | 0.02 | 0.25 | 0.5 | 0.55 |
| (二)稀释每股收益 | 0.02 | 0.25 | 0.5 | 0.55 |
| 八、其他综合收益 | 986,432.02 | -4,122,565.46 | -3,433,573.73 | -3,324,650.96 |
| 归属于母公司股东的其他综合收益 | 892,030.48 | -3,728,035.95 | -3,104,980.72 | -3,006,481.86 |
| 九、综合收益总额 | 4,697,904.73 | 44,424,584.72 | 64,376,453.43 | 63,455,115.72 |
| 归属于母公司股东的综合收益总额 | 3,962,759.13 | 41,875,955.03 | 58,052,493.7 | 56,961,099.62 |
| 归属于少数股东的综合收益总额 | 735,145.6 | 2,548,629.69 | 6,323,959.73 | 6,494,016.1 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-21 | 2023-07-31 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |